Impact of Bright Light Therapy on Prader-Willi Syndrome
A Randomized, Double-Blind, Controlled Trial of Bright Light Therapy on All-Cause Excessive Daytime Sleepiness in Prader-Willi Syndrome
Maimonides Medical Center
30 participants
Oct 1, 2023
INTERVENTIONAL
Conditions
Summary
This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome
Eligibility
Inclusion Criteria2
- Diagnosis of PWS confirmed by genetic testing
- Score of 12 or above on the Epworth Sleepiness Scale (ESS).
Exclusion Criteria3
- Subjects with an eye condition that could be negatively affected by bright light such as patients with a history of retinal damage or patients needing photosensitizing medications
- A history of previous treatment with LT
- Patients presenting with active psychosis or mania
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Sham treatment will be provided from a light box at a distance of at least 70cm but no greater than 90cm.
Bright Light Therapy will be provided using light box with an artificial full spectrum lamp at a distance of at least 70cm but no greater than 90cm.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05939453